{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidjkrg2ykrdoopnqge3jqci3w7sy3ctvxlzaititqeojhlvgeqo4y",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mhmcqt67ilc2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidgwbtujefshw2kclc7zfbugjkx5nu4jmcwbbcumeod3u3642cnc4"
    },
    "mimeType": "image/jpeg",
    "size": 513161
  },
  "path": "/news/2026-03-psychedelic-drug-mdma-ptsd-widely.html",
  "publishedAt": "2026-03-21T20:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "About 11% of Australians will develop post-traumatic stress disorder (PTSD) at some point in their life.",
  "title": "Psychedelic drug MDMA could help treat PTSD—but there's a reason it's not widely available"
}